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Introduction
Endometriosis and adenomyosis are related chronic diseases affecting women of reproductive age. Endometriosis is characterized by the presence of endometrium-like tissue outside the uterus, typically in the pouch of Douglas, whereas adenomyosis is defined by in-growth of the endometrium into the myometrium (1) . The two diseases coexist in some but not all patients (2) and both diseases may be linked to structural and functional changes in the submucosal proportion of the myometrium, the so-called junctional zone (1) . In endometriosis, junctional zone dysfunction may afford the retrograde menstruation thought to be an initial step in the pathogenesis (3), whereas more pronounced junctional zone changes are seen in adenomyosis (1) .
The prevalences are not clearly established. In the general population, endometriosis is estimated to affect approximately 10%, and up to 35-50% of infertile women are affected (4, 5) . The prevalence of adenomyosis is even more uncertain, with reports varying from 5 to 35% in the general population (5) .
Although the two diseases share symptoms of pelvic pain and abnormal menstrual bleeding, there are important differences. Adenomyosis is defined as endometrial cells in the myometrium accompanied by muscular hyperplasia, hypertrophy and fibrosis (2) ; the ectopic endometrium-like tissue can be widespread in women with endometriosis (4) . Furthermore, endometriosis is most common among young women and is known to affect fertility, whereas infertility is less common in women with adenomyosis (2, (4) (5) (6) (7) . Nevertheless, as more and more women postpone their first pregnancy, endometriosis and adenomyosis increasingly affect fertility and pregnancy outcomes.
In recent years, there has been a growing focus on potential adverse pregnancy outcomes among women suffering from endometriosis or adenomyosis, and associations with obstetrical complications have been suggested such as miscarriages, late pregnancy complications, preterm delivery and having a child that is small for gestational age (SGA) (8) . Several studies have investigated whether women with endometriosis and adenomyosis have a higher risk of having a child born preterm or SGA, but results have pointed in opposite directions .
A recent meta-analysis found that women with endometriosis have a higher risk of preterm delivery and SGA (30) ; however, they did not evaluate adenomyosis. It has been suggested that both endometriosis and adenomyosis could be associated with obstetrical complications (8) , and speculation on whether adenomyosis poses a larger threat to the pregnancy exist. Hence, keeping the suggested etiological associations between the two diseases in mind, it is important to study available data to assess whether the risk of preterm delivery and SGA in women with adenomyosis is as high as or even higher than in women with endometriosis. The main objective of this systematic review and meta-analysis was therefore to reassess the association between endometriosis and the risk of preterm delivery and SGA as well as to investigate whether women with adenomyosis have a higher risk of preterm delivery and SGA.
Material and methods
This systematic review and meta-analysis was performed in accordance with the PRISMA guidelines (31) .
Information sources
A systematic computerized literature search of articles published from 1950 to October 2017 was conducted for all published articles in the databases PubMed and Embase. In PubMed, the complete search words entered were: (("Infant, Low Birth Weight" [Mesh] OR "Infant, Premature" [Mesh] ) OR "Birth Weight" [Mesh] ) OR preterm) OR premature) OR sga) OR "small for gestational")) AND ((endometriosis) OR adenomyosis). The corresponding search in Embase was: 'endometriosis'/exp OR endometriosis OR 'adenomyosis'/exp OR adenomyosis AND 'low birth weight'/exp OR 'prematurity'/exp OR 'birth weight'/exp OR 'Immature and premature labor'/exp OR 'small for date infant'/exp. References were collected using EndNote. No restrictions to study design and language were listed in the initial search. Furthermore, the reference list of the eligible studies was screened for additional relevant articles.
Study selection and data extraction
Eligibility criteria. Inclusion criteria were English language studies, epidemiological observational studies and studies investigating the associations between endometriosis or adenomyosis and the outcomes preterm delivery and/or SGA. Preterm delivery was defined as live birth < 37 weeks of gestation and SGA was defined as birthweight < 10th centile for gestational age.
Exclusion criteria were meta-analyses, case reports and studies with lack of relevance or insufficient data reporting. Lack of relevance included studies where results for women with endometriosis or adenomyosis were not compared with results for women without endometriosis or adenomyosis. Studies were excluded from the final meta-analysis if the associations were not reported as crude or adjusted odds ratios (OR) or relative risks with 95% confidence interval (95% CI) or if the authors had not provided data that could be used to calculate crude OR with 95% CI.
Screening of studies. In the screening of relevant studies, duplicates were removed before abstract screening. Two authors (MRB, LHA) independently reviewed all studies and any discrepancies were resolved by consensus. First, all studies identified in the initial search were reviewed based on the title and subsequently, based on the abstract. Studies considered relevant based on titles and abstracts were read in full text by two of the authors (MRB, LHA) to identify papers that met the inclusion criteria.
The corresponding authors of three studies were contacted with questions concerning the composition of the study population (one paper), and the precise definition of preterm delivery (two papers). Based on their answers, one study was continuously included (14) , another study was excluded as the outcome was threatened premature delivery (32) , and the third study on preterm delivery was excluded as it only assessed preterm delivery <34 weeks of gestation, and their results on SGA were included (9) .
Assessment of risk of bias.
To assess the quality of the studies included, we used the Newcastle-Ottawa Quality Assessment Scale (NOS) in which studies are scored individually between zero and nine, based upon an evaluation of selection and comparability of the study groups as well as the ascertainment of exposure and outcome (33) . Two authors (MRB, LHA) independently evaluated the quality of each included study using the NOS. If disagreement between the assessed score of a study occurred, the reviewers discussed and evaluated the study to reach agreement. If necessary, a third reviewer was consulted (CHR).
Statistical analyses
Most studies stated crude or adjusted OR with 95% CI. In studies providing both crude and adjusted OR, we used the adjusted OR. In the studies that did not state the OR with 95% CI, the statistical tool, EPIBASIC was applied to calculate crude OR with 95% CI on the basis of the data presented in the study. An independent calculation of an OR for each study based on the number of exposed and non-exposed would result in a crude OR for each study. It would otherwise not have been possible for us to perform a sub-analysis of studies with adjusted results, which we consider a better estimate of the true association between endometriosis or adenomyosis and adverse pregnancy outcomes. Furthermore, not all studies provided sufficient data to calculate an OR. Therefore, we only calculated an OR if the studies did not report an adjusted OR.
REVIEW MANAGER 5 software was used to conduct the meta-analysis (34) . A random-effect inverse-variance weighted model for combining OR was used, resulting in a combined summary OR with 95% CI (35) . Main analyses were performed for the association between the two exposures, endometriosis and adenomyosis, and the two outcomes, preterm delivery and SGA, separately. The overall comparison was performed including several outcomes, the random effects model and the effect measure of OR and 95% CI. With this method, OR and the lower limit of the 95% CI from each study could be inserted into the calculator function, which resulted in an upper limit of the 95% CI as well as a logarithm of OR and a standard error for each study. A combined OR with 95% CI was calculated by uniting each log(OR) and associated standard error. For each study, a weighted estimate was calculated using log (OR) and standard error. Hence, studies with most weight were rated more important in the final estimate. The resulting upper limits of the 95% CI were not consistently identical to the upper limit for the OR stated in the studies because of small differences in the round off of numbers. Further, REVIEW MANAGER 5 was used to assess the risk of publication bias based on funnel plots.
For endometriosis, we also performed the following sensitivity analyses: we restricted the analyses to studies reporting adjusted OR and 95% CI; we restricted the analyses to studies that only included singleton births; and we restricted the analyses to studies with a score of ≥8 on the NOS. For adenomyosis, one study in the main analysis included women with untreated rectovaginal deep infiltrating endometriosis in some women also including adenomyosis (27) . However, accurate information on exposure was not provided and it was not possible to discern women with rectovaginal deep infiltrating endometriosis from women with adenomyosis or whether the diseases coexisted. For that reason, the study was excluded in the sub-analyses on the association between adenomyosis and birthweight and SGA (27) . Figure 1 illustrates the flowchart of studies identified in the literature search and included in the systematic review and meta-analysis. In total, 21 studies published between 2003 and 2017 on the association between endometriosis or adenomyosis and preterm delivery or SGA among a total of 2 517 516 women were included. Among all studies, 20 were cohort studies and one was a case-control study. Eleven studies were from Europe, seven studies from Asia, two studies from America and one study was from Australia. Of the 21 studies, four included adenomyosis, whereas 17 studies consisted of different sub-types of endometriosis including superficial endometriosis, deep peritoneal endometriosis and endometriomata. preterm delivery (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . The meta-analyses showed that women with endometriosis had a higher odds of preterm delivery (OR 1.47, 95% CI 1.28-1.69) than women without endometriosis (Figure 2a ). This finding was consistent across the sensitivity analyses performed. First, the analysis was restricted to the 13 studies reporting adjusted ORs, and we observed an OR of 1.48 (95% CI 1.28-1.71) (see Supplementary material, Figure S1 ). Second, the analysis was repeated, but was limited to 14 studies with singleton births only and we found an OR of 1.45 (95% CI 1.26-1.68) (see Supplementary material, Figure S2 ). Finally, assessing the quality of the included studies, Figure S3 ). Heterogeneity (I 2 = 55%, p = 0.005) between the included studies was high.
Results
A sub-analysis including one relevant conference abstract was also performed (36) . This conference abstract did not state sufficient relevant data to be included in the main analysis and it was not possible to assess the quality using NOS because of sparse information. The sub-analysis on endometriosis and preterm delivery resulted in an OR of 1.46 (95% CI 1.29-1.66) and a rather high heterogeneity (I 2 = 52%, p = 0.006). These results did not differ considerably from the main results.
Small for gestational age. Of the total of 21 studies, 13 described the association between endometriosis and SGA (9,10,14-18,20-25). The meta-analysis revealed a higher risk of having an SGA child among women with endometriosis, with an overall OR of 1.26 (95% CI 1.04-1.54) (Figure 2b ). When only the adjusted OR was included, very similar results were found (OR 1.26, 95% CI 1.01-1.56] (see Supplementary material, Figure S4 ). When only assessing the associations among singleton births, an OR of 1.24 (95% CI 0.99-1.56) was found (see Supplementary material, Figure S5) . Further, five studies reached a NOS score ≥ 8 and the meta-analysis of these showed attenuated results (OR 1.13, 95% CI 0.88-1.46) (see Supplementary material, Figure S6) . A rather high heterogeneity (I 2 = 72%, p < 0.0001) between studies was observed. Funnel plots were made to depict the association between endometriosis and preterm delivery and SGA. The asymmetry in both funnel plots aroused suspicion that publication bias could exist because small studies were not published (see Supplementary material, Figures  S7 and S8 ).
Adenomyosis
Preterm delivery. A total of four studies were identified investigating the association between adenomyosis and preterm delivery (26) (27) (28) (29) . The meta-analysis revealed even higher odds of preterm delivery in pregnant women with adenomyosis compared with pregnant women without adenomyosis (OR 3.09, 95% CI 1.88-5.09)] (Figure 2c) . The sub-analysis restricted to three studies provided similar results with only a small reduction in OR to 2.90 (95% CI 1.59-5.28) (see Supplementary material, Figure S9) .
A rather high heterogeneity (I 2 = 41%, p = 0.16) was observed between the four studies included in the metaanalysis.
Small for gestational age
In total, three studies evaluated the association between adenomyosis and SGA (26) (27) (28) . There was a higher risk of SGA in pregnant women with adenomyosis compared with pregnant women without adenomyosis (OR 3.23, 95% CI 1.71-6.09) (Figure 2d) . A sub-analysis restricted to two studies on adenomyosis found an OR of 3.96 (95% CI 2.02-7.78) (see Supplementary material, Figure S10) . A rather low heterogeneity (I 2 = 4%, p = 0.35) was found between the three studies included in the meta-analysis.
As only a few studies were included in the association between adenomyosis and preterm delivery and SGA, respectively, it was not possible to perform sub-analyses as we had for endometriosis. Further, the information gained from the funnel plots was sparse and no conclusion regarding risk of publication bias could be reached (see Supplementary material, Figures S11 and S12) .
Overall, studies on the association between endometriosis and preterm delivery and SGA have pointed in different directions; some reported an increased risk of preterm delivery (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (22) (23) (24) and having an SGA child (9, (14) (15) (16) (17) (18) 20, (23) (24) (25) , whereas other did not support this (10, (20) (21) (22) 25) . Regarding adenomyosis, all published studies found an increased risk of preterm delivery (26) (27) (28) (29) and SGA (26) (27) (28) , but with considerable differences in the strength of the association.
Discussion
Results of the meta-analysis including 21 studies and a total of 2 517 516 women, supported our hypothesis that women with endometriosis and adenomyosis have an increased odds of preterm delivery and SGA. Women with adenomyosis had the highest odds of both preterm delivery and SGA.
Recent systematic reviews and meta-analyses found that women with endometriosis have an increased risk of preterm delivery (30, 37) and SGA (30) . To the best of our knowledge, no previous systematic reviews and meta-analyses have assessed the association between adenomyosis and adverse birth outcomes.
It has repeatedly been debated whether endometriosis and adenomyosis are in fact part of a continuum of diseases or separate entities (1, 2, 38) . Studies have suggested that both diseases could develop based on a disturbed uterine peristalsis and dislocation of the basal endometrium (1, 6, 38, 39) . Further endometriosis-related factors potentially involved in adverse pregnancy outcomes include reactive oxygen species formation, inflammation and progesterone resistance (40) . Preterm delivery and SGA are associated with both short-term and long-term complications for the child. Neonates born preterm or SGA have a higher short-term mortality and neonatal morbidity, including among others brain hemorrhage, temperature instability and respiratory distress (41, 42) . Long-term sequelae of preterm delivery include, depending on degree of prematurity, neurodevelopmental disability, bronchopulmonary dysplasia and prematurity retinopathy (41, 43) , as well as metabolic syndrome and cardiovascular disease in adulthood for SGA (42, 43) . As preterm delivery and SGA are significant predictors for both short-term and long-term health of the offspring, knowledge on whether endometriosis or adenomyosis is associated with these adverse birth outcomes has important and also clinical implications.
This study has strengths as well as limitations that may have influenced the results. It represents a large and comprehensive meta-analysis based on 21 studies with a novel focus on adenomyosis. In previous meta-analyses it was not considered whether multiple births might have affected the results. We consider this very important, as twinning is highly associated with preterm delivery or SGA. Additionally, endometriosis is associated with infertility and need for assisted reproductive technology (ART), which increases the probability of multiple births. For that reason, a sub-analysis was conducted on the association between endometriosis and the risk of preterm delivery and SGA only among singleton births. The strong association between endometriosis and delivering preterm persisted, indicating that this association is not only affected by twinning; the association between endometriosis and SGA attenuated slightly.
Conception by ART also increases the risk of SGA and preterm delivery (44) . Glavind et al. (10) therefore stratified their birth cohort data according to use of ART, but their findings of an increased risk of both pregnancy complications in endometriosis patients remained essentially the same.
In general, limitations of meta-analyses include an increased risk of reporting bias as papers supporting strong associations are most likely to be published. Furthermore, quality of the meta-analysis depends on the internal validity of each study. In this study, two independent authors evaluated all included studies and each study was assessed with the NOS. This information was subsequently used in sub-analyses, restricted to studies with a NOS score ≥ 8, and so a high internal validity, to assess the validity of the main results. In the sensitivity analyses, we found similar results to those reported in the main analysis, but not for the association between endometriosis and SGA. Another aspect that might have affected results is the quality of information on exposure and outcome. The included studies differed in their ascertainment on endometriosis and adenomyosis. Furthermore, not all studies distinguished explicitly between the two conditions. This could result in analysis of adverse birth outcomes in a mixed group. Information could be derived from medical registers, medical reports or self-reports. Besides, information on endometriosis and adenomyosis could be derived from descriptions following surgical treatment, laparoscopy, magnetic resonance imaging or transvaginal ultrasonography. However, we are quite certain that outcomes in each study were most likely correctly defined, as preterm delivery is defined as a live birth at < 37 weeks of gestation and SGA is defined as a birthweight < 10th centile of gestational age. Further, it is a simple and standard task to collect information on preterm delivery and SGA. Nevertheless, it is important to keep in mind that preterm delivery and SGA are different but related outcomes with both individual and common risk factors and both shortterm and long-term complications for the newborn (45) . In general, studies included in this systematic review did not distinguish elective from spontaneous preterm deliveries. Furthermore, the included studies provided no detailed information on either treatment or severity of endometriosis and adenomyosis. This could complicate the comparison between studies.
Among the 21 included studies, not all were adjusted for potential confounders and there may be residual confounding. Results from the sub-analysis of studies with adjusted results were consistent for preterm delivery but slightly attenuated for SGA. For all main analyses, apart from the association between adenomyosis and SGA, heterogeneity was high, which indicates that studies were not completely comparable.
For adenomyosis, it was not possible to conduct subanalyses as for endometriosis due to the small number of relevant studies. One study included in our meta-analysis did not distinguish women with adenomyosis from women with rectovaginal deep infiltrating endometriosis, which could give rise to bias (27) . A sub-analysis was therefore made excluding this study, However, this only changed the results for preterm delivery and SGA to a minor extent. Further, one of the included studies on adenomyosis included adjusted results and received a NOS score ≥8 (29) , whereas the other studies did not provide adjusted results and obtained NOS scores <8 (26) (27) (28) . Lacking adjustment could result in confounding, especially considering maternal age, because adenomyosis is often seen in older women, and age could affect the association between adenomyosis and adverse pregnancy outcomes. All studies on adenomyosis presented results on singleton births, which made it possible to assess the association between adenomyosis and preterm delivery and SGA without twinning being an effect modifier. Hence, our findings on adverse birth outcomes among women with adenomyosis are strengthened as they only included singleton births.
Overall, this systematic review and meta-analysis indicated that women with endometriosis and adenomyosis are at higher risk of preterm delivery and SGA. The clinical relevance for the risk of preterm delivery in endometriosis patients is further corroborated by specific findings in two recent studies included in our material where the study size enabled a more detailed analysis. These results showed an increased risk of very preterm (<32 weeks of pregnancy) (10) and extremely preterm delivery (<28 weeks of pregnancy) (9) in women with endometriosis. Additionally, both endometriosis (4) and preterm delivery (46) are relatively frequent. Therefore, the association between endometriosis and preterm delivery shows an important risk profile as the total number of affected women may be substantial.
The meta-analysis further indicated that women with adenomyosis faced the highest risks, although the result was based on few original studies and consequently uncertain estimates with wide confidence intervals. The increased risk persisted when one study with very uncertain classification of endometriosis and adenomyosis was excluded. However, the findings for endometriosis may have been impacted by the simultaneous presence of adenomyosis as this disease is more prevalent in patients with endometriosis (47, 48) . Further research with a detailed prepregnancy diagnosis is needed to assess the specific risk profile for the two diseases separately and in combination. Although speculative, adenomyosis could well be associated with more adverse pregnancy outcomes compared with endometriosis due to the more pronounced junctional zone changes suggested (1, 6, 38) . Additionally, potential pathogenic mechanisms for both diseases include inflammation and enhanced formation of reactive oxygen species (2, 40) .
Conclusion
In conclusion, this systematic review and meta-analysis including 21 studies and a total of 2 517 516 women support the hypotheses that women with endometriosis or adenomyosis have a higher risk of preterm delivery and having an SGA child. It should be noted that the risk seemed to be higher among women with adenomyosis, and future studies should seek to explore this further. This study may suggest a closer prenatal monitoring of pregnant women suffering from endometriosis and adenomyosis to prevent adverse birth outcomes.
Funding
No specific funding.
Supporting information
Additional Supporting Information may be found in the online version of this article: Figure S1 . Endometriosis sub-analysis of adjusted OR and preterm delivery. Figure S2 . Endometriosis sub-analysis of only singleton births and preterm delivery. Figure S3 . Endometriosis sub-analysis of NewcastleOttawa Scale score of ≥ 8 and preterm delivery. Figure S4 . Endometriosis sub-analysis of adjusted OR and small for gestational age. Figure S5 . Endometriosis sub-analysis of only singleton births and small for gestational age Figure S6 . Endometriosis sub-analysis of NewcastleOttawa Scale score of ≥ 8 and small for gestational age. Figure S7 . Funnel plot for endometriosis and preterm delivery. Figure S8 . Funnel plot for endometriosis and small for gestational age. Figure S9 . Adenomyosis sub-analysis of preterm delivery -Exacoustous et al. excluded. Figure S10 . Adenomyosis sub-analysis of small for gestational age -Exacoustous et al. excluded. Figure S11 . Funnel plot for adenomyosis and preterm delivery. Figure S12 . Funnel plot for adenomyosis and small for gestational age.
